Redcare Pharmacy N.V.: Redcare Pharmacy reports stronger than expected Q2 2026 quarter-to-date trading and raises its full-year 2026 outlook.
15.06.2026 - 16:16:44 | dgap.de| EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Forecast / Full year/Forecast / Full year 15-Jun-2026 / 16:16 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Redcare Pharmacy reports stronger than expected Q2 2026 quarter-to-date trading and raises its full-year 2026 outlook. Sevenum, the Netherlands, June 15, 2026. Today, Redcare Pharmacy announced preliminary trading figures for the quarter-to-date period of Q2 2026, covering the first two months of the quarter. Trading came in stronger than expected, with YoY growth accelerating versus Q1 2026 and as well MoM in Q2. As a result, Redcare Pharmacy has raised its full-year 2026 guidance. The Company now expects: Total revenue growth of 15% to 17% (previously: 13% to 15%) Non-Rx growth of 10% to 12% (previously: 8% to 10%) Rx revenue in Germany between EUR 680 to 720 million, representing growth of 35% to 43% (previously: in excess of EUR 670 million) Adjusted EBITDA margin between 2.5% and 3.0% (previously: in excess of 2.5%). Contact: Irina Zhurba Investor Relations End of Inside Information 15-Jun-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | investors@redcare-pharmacy.com |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX |
| EQS News ID: | 2346348 |
| End of Announcement | EQS News Service |
| |
2346348 15-Jun-2026 CET/CEST
en | NL0012044747 | REDCARE PHARMACY N.V. | boerse | 69545173 |
